Treat the health of your entire healthcare system. DLA Piper's lawyers provide guidance to help you tend to your system's wellness throughout the business life cycle.     A rare confluence of factors is generating great opportunities for private equity and strategic buyers healthcare. To help stakeholders mitigate risk and maximize return, we review both the market forces now in play and key business and legal requirements.     The 21st Century Cures Act, signed into law by President Barack Obama in December 2016 with broad bipartisan support, will have a meaningful effect on hospitals, behavioral health providers, and many other providers. Understanding its key components will be critical.     Vermont's statewide test of value-based purchasing is putting into practice the latest CMS ideas about the structure of future healthcare funding. See our report.     The DOJ is keeping a sharp focus on healthcare fraud enforcement – we report on the 2016 stats and analyze the trends behind the numbers.     Cybersecurity updates to medical devices already in the field can trigger FDA reporting. What do device manufacturers need to know to understand their obligations under Part 806?     Healthcare companies paid more than half of the $3.5 billion in settlements and judgments collected by the DOJ in 2015 in fraud and false claims cases, and federal enforcers are ramping up their False Claims Act efforts. We offer steps toward assessing and enhancing your compliance program.     HHS issues its final rule to improve public access to information about specified clinical trials involving FDA-regulated products. See our chart setting out the key changes.     In draft guidance on data integrity current Good Manufacturing Practices, FDA warns pharma companies that compliance is a top enforcement focus. What new insight does the draft guidance lend about agency expectations?     CMS Final Rule: anyone receiving an overpayment from Medicare or Medicaid must report and return the overpayment within 60 days. What steps should you ponder when you suspect overpayment?     How is technology transforming the way we deliver care? See the high points from the JPMorgan panel of healthcare innovators – entrepreneurs, investors and providers.           Learn more To learn more about the ways DLA Piper can support the health of your healthcare system, please contact Joshua Kaye, Chair, US Healthcare Sector.